Capital Fund Management (CFM)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-34,876
Closed -$4.34M – 2649
2025
Q2
$4.34M Buy
+34,876
New +$4.44M 0.01% 1233
2024
Q4
– Sell
-13,656
Closed -$2.03M – 2217
2024
Q3
$2.03M Buy
+13,656
New +$1.96M 0.01% 1428
2020
Q1
– Sell
-2,700
Closed -$250K – 1945
2019
Q4
$250K Buy
+2,700
New +$227K ﹤0.01% 1668
2019
Q2
– Sell
-6,600
Closed -$390K – 1865
2019
Q1
$390K Buy
6,600
+1,300
+25% +$74.8K ﹤0.01% 1343
2018
Q4
$280K Buy
+5,300
New +$311K ﹤0.01% 1630
2016
Q1
– Sell
-14,600
Closed -$413K – 1788
2015
Q4
$413K Sell
14,600
-1,700
-10% -$49K ﹤0.01% 1186
2015
Q3
$454K Buy
+16,300
New +$589K 0.01% 1076
2015
Q2
– Sell
-8,200
Closed -$249K – 1674
2015
Q1
$249K Buy
+8,200
New +$213K ﹤0.01% 1308
2014
Q2
– Sell
-23,497
Closed -$302K – 1884
2014
Q1
$302K Buy
+23,497
New +$337K ﹤0.01% 1474

Other funds holding RGEN

Capital Fund Management (CFM)'s RGEN Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Repligen (RGEN) in Q3 2025, closing a stake of 34,876 shares — an estimated $4.34M sold.

Capital Fund Management (CFM) first reported a position in RGEN in Q1 2014 and held it in 9 quarters. The position peaked at $4.34M in Q2 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 34,876 Repligen shares in Q3 2025, an estimated $4.34M.
  • Capital Fund Management (CFM) first reported a position in Repligen in Q1 2014 and held it in 9 quarters.
  • Capital Fund Management (CFM)'s Repligen position peaked at $4.34M in Q2 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.